Original Research Obstetrics| Volume 222, ISSUE 5, P495.e1-495.e8, May 2020

Early gestational diabetes screening in obese women: a randomized controlled trial

Published:January 09, 2020DOI:


      Although in 2013 the American College of Obstetricians and Gynecologists recommended early screening for gestational diabetes in obese women, no studies demonstrate an improvement in perinatal outcomes with this strategy.


      We sought to determine whether early screening for gestational diabetes improves perinatal outcomes in obese women.

      Materials and Methods

      Randomized controlled trial comparing early gestational diabetes screening (14−20 weeks) to routine screening (24−28 weeks) in obese women (body mass index ≥30 kg/m2) at 2 tertiary care centers in the United States. Screening was performed using a 50-g, 1-hour glucose challenge test followed by a 100-g, 3-hour glucose tolerance test if the initial screen was ≥135 mg/dL. Gestational diabetes was diagnosed using Carpenter−Coustan criteria. Women not diagnosed at 14 to 20 weeks were rescreened at 24 to 28 weeks. Exclusion criteria were pre-existing diabetes, major medical illness, bariatric surgery, and prior cesarean delivery. The primary outcome was a composite of macrosomia (>4000 g), primary cesarean delivery, hypertensive disease of pregnancy, shoulder dystocia, neonatal hyperbilirubinemia, and neonatal hypoglycemia (assessed within 48 hours of birth).


      A total of 962 women were randomized, and outcomes were available for 922. Of these 922 women, 459 (49.8%) were assigned to early screen and 463 (50.2%) to routine screen. Baseline characteristics were balanced between groups. In the early screening group, 69 (15.0%; 95% confidence interval, 11.9−18.6%) were diagnosed with gestational diabetes: 29 (6.3%; 95% confidence interval, 4.3−8.9%) at <20 weeks and 40 (8.7%; 95% confidence interval, 6.3−11.7%) at >24 weeks. Of those randomized to routine screening, 56 (12.1%; 95% confidence interval, 9.3−15.4%) had gestational diabetes. Early screening did not reduce the incidence of the primary outcome (56.9% in the early screen versus 50.8% in the routine screen, P = .07; relative risk, 1.12; 95% confidence interval, 0.99−1.26).


      Early screening for gestational diabetes in obese women did not reduce the composite perinatal outcome.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Centers for Disease Control and Prevention
        National Center for Health Statistics. 2016; (Selected health conditions and risk factors, by age: United States, selected years 1988-1994 through 2015-2016. Available at:)
        • Dodd J.M.
        • Grivell R.M.
        • Nguyen A.M.
        • Chan A.
        • Robinson J.S.
        Maternal and perinatal health outcomes by body mass index category.
        Aust N Z J Obstet Gynaecol. 2011; 51: 136-140
        • ACOG Practice Bulletin
        Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes.
        Obstet Gynecol. 2001; 98: 525-538
        • Crowther C.A.
        • Hiller J.E.
        • Moss J.R.
        • McPhee A.J.
        • Jeffries W.S.
        • Robinson J.S.
        Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.
        N Engl J Med. 2005; 352: 2477-2486
        • Landon M.B.
        • Spong C.Y.
        • Thom E.
        • et al.
        A multicenter, randomized trial of treatment for mild gestational diabetes.
        N Engl J Med. 2009; 361: 1339-1348
        • Roman A.S.
        • Rebarber A.
        • Fox N.S.
        • et al.
        The effect of maternal obesity on pregnancy outcomes in women with gestational diabetes.
        J Matern Fetal Neonatal Med. 2011; 24: 723-727
        • ACOG
        ACOG committee opinion number 315, September 2005. Obesity in pregnancy.
        Obst Gynecol. 2005; 106: 671-675
        • American College of Obstetricians and Gynecologists
        Practice Bulletin No. 137: Gestational diabetes mellitus.
        Obstet Gynecol. 2013; 122: 406-416
        • Landon M.B.
        • Rice M.M.
        • Varner M.W.
        • et al.
        Mild gestational diabetes mellitus and long-term child health.
        Diabetes Care. 2015; 38: 445-452
        • Mission J.F.
        • Catov J.
        • Deihl T.E.
        • Feghali M.
        • Scifres C.
        Early pregnancy diabetes screening and diagnosis: prevalence, rates of abnormal test results, and associated factors.
        Obstet Gynecol. 2017; 130: 1136-1142
        • US Preventive Services Task Force
        Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.
        Ann Intern Med. 2008; 148: 759-765
        • Wexler D.J.
        • Powe C.E.
        • Barbour L.A.
        • et al.
        Research gaps in gestational diabetes mellitus: executive summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
        Obstet Gynecol. 2018; 132: 496-505
        • Carpenter M.W.
        • Coustan D.R.
        Criteria for screening tests for gestational diabetes.
        Am J Obstet Gynecol. 1982; 144: 768-773
        • O'Sullivan J.B.
        • Mahan C.M.
        Criteria for the oral glucose tolerance test in pregnancy.
        Diabetes. 1964; 13: 278-285
        • Stiewig M.
        • Jackson D.N.
        • Howard D.L.
        Does serum hemoglobin A1C during early pregnancy predict performance on the 1-hour glucose challenge test?.
        J Matern Fetal Neonatal Med. 2019; : 1-3
        • American Diabetes Association Professional Practice Committee
        Professional Practice Committee: standards of medical care in diabetes—2019.
        Diabetes Care. 2019; 42: S13-S27
        • ACOG
        Practice bulletin no. 137: gestational diabetes mellitus.
        Obstet Gynecol. 2013; 122: 406-416
        • Duryea E.L.
        • Hawkins J.S.
        • McIntire D.D.
        • Casey B.M.
        • Leveno K.J.
        A revised birth weight reference for the United States.
        Obstet Gynecol. 2014; 124: 16-22
        • Boulet S.L.
        • Alexander G.R.
        • Salihu H.M.
        • Pass M.
        Macrosomic births in the United States: determinants, outcomes, and proposed grades of risk.
        Am J Obstet Gynecol. 2003; 188: 1372-1378
        • American College of Obstetricians and Gynecologists
        ACOG practice bulletin no. 202: gestational hypertension and preeclampsia.
        Obstet Gynecol. 2019; 133: e1-e25
        • American Academy of Pediatrics Subcommittee on Hyperbilirubinemia
        Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.
        Pediatrics. 2004; 114: 297-316
        • Maisels M.J.
        • Watchko J.F.
        • Bhutani V.K.
        • Stevenson D.K.
        An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation.
        J Perinatol. 2012; 32: 660-664
        • Hong W.Y.
        • Biggio J.R.
        • Tita A.
        • Harper L.M.
        Impact of early screening for gestational diabetes on perinatal outcomes in high-risk women.
        Am J Perinatol. 2016; 33: 758-764
        • Feghali M.N.
        • Abebe K.Z.
        • Comer D.M.
        • Caritis S.
        • Catov J.M.
        • Scifres C.M.
        Pregnancy outcomes in women with an early diagnosis of gestational diabetes mellitus.
        Diabetes Res Clin Pract. 2018; 138: 177-186
        • Osmundson S.S.
        • Norton M.E.
        • El-Sayed Y.Y.
        • Carter S.
        • Faig J.C.
        • Kitzmiller J.L.
        Early screening and treatment of women with prediabetes: a randomized controlled trial.
        Am J Perinatol. 2016; 33: 172-179
        • Roeder H.A.
        • Moore T.R.
        • Wolfson M.T.
        • Gamst A.C.
        • Ramos G.A.
        Treating hyperglycemia in early pregnancy: a randomized controlled trial.
        Am J Obstet Gynecol MFM. 2019; 1: 33-41
        • American College of Obstetricians and Gynecologists
        ACOG practice bulletin no. 190: gestational diabetes mellitus.
        Obstet Gynecol. 2018; 131: e49-e64